Somatogen
Executive Summary
Commences 2 mil. share public offering at $ 19 per share Aug. 2. The company plans to use the proceeds to fund new manufacturing facilities and development costs for its first product, rHb 1.1 ("The Pink Sheet" July 1, T&G-8).